PROAstraZeneca
stock12,026.00p
+28.00 (+0.23%)
Price as of 13 Oct, 15:45 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Neutral
Mixed investment profile
Technical Analysis
Short-Term Outlook
Neutral
2 bull · 2 bear · 1 neutral
Medium-Term Outlook
Bearish
0 bull · 4 bear · 0 neutral
Price below 50-day MA
Price below 200-day MA
Price below 12-day EMA
Price below 26-day EMA
Neutral momentum zone
MACD below signal line
Oversold — potential reversal up
Price near lower band — potential bounce
Volatility measure — informational only
Market Statistics
Day Change
+28.00p
Exchange
LSE
Sector
Pharmaceuticals & biotechnology
FCA Net Short Position
No net short positions disclosed for this stock.
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Learn about AstraZeneca
What is AstraZeneca?
AstraZeneca is a global pharmaceutical company focused on discovering, developing, and commercializing prescription medicines in areas such as oncology, cardiovascular, and respiratory diseases. The company invests heavily in research and development to bring innovative treatments to market for complex health conditions worldwide.
Is AstraZeneca a good investment?
Investors often look at AstraZeneca for its robust pipeline of new drugs and consistent dividend payments, though the company faces risks such as patent expirations and the inherent unpredictability of clinical trials. It is important to weigh these factors against your own risk appetite, as this information is for educational purposes only and does not constitute financial advice.
How do you invest in AstraZeneca?
You can invest in AstraZeneca by purchasing shares directly through a regulated online stockbroker or investment platform. Alternatively, you may choose to gain indirect exposure by investing in mutual funds or exchange-traded funds (ETFs) that hold the stock within their broader pharmaceutical or healthcare portfolios.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for AZN — be the first to start the discussion.
Point & Figure Analysis
Famous Investors Holding AZN
Ken Fisher
11.15M sh · 0.6% of portfolio
$2.11B
NEW
Ken Griffin
952.1K sh · 0.0% of portfolio
$180.54M
NEW
Ken Griffin
513.3K sh · 0.0% of portfolio
$97.33M
NEW
Ken Griffin
212.9K sh · 0.0% of portfolio
$40.38M
NEW
Ken Griffin
18.0K sh · 0.0% of portfolio
$3.40M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.